Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Csl Ltd ADR (CSLLY)

Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 85,013,776
  • Shares Outstanding, K 966,505
  • Annual Sales, $ 13,310 M
  • Annual Income, $ 2,194 M
  • 60-Month Beta 0.73
  • Price/Sales 6.38
  • Price/Cash Flow 28.54
  • Price/Book 4.84
Trade CSLLY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 09/27/23
  • Annual Dividend & Yield 1.14 (1.30%)
  • Most Recent Dividend 0.545 on 03/11/24
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.7950 +0.04%
on 04/18/24
95.8300 -9.39%
on 03/28/24
-4.5980 (-5.03%)
since 03/18/24
3-Month
86.7950 +0.04%
on 04/18/24
99.5400 -12.77%
on 01/31/24
-6.8580 (-7.32%)
since 01/18/24
52-Week
71.5100 +21.43%
on 10/30/23
105.1100 -17.39%
on 06/13/23
-13.9280 (-13.82%)
since 04/18/23

Most Recent Stories

More News
CSL Appoints Jeffrey Ball as First Chief Sustainability Officer

/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) (USOTC: CSLLY) announced today that Jeffrey Ball, an established global leader across multiple...

CSL : 367.54 (-0.35%)
CSLLY : 86.8320 (-1.28%)
5 Diverse Medical Stocks to Buy for 2023 and Beyond

The top and bottom-line growth make these Zacks Medical stocks very attractive.

NVO : 122.77 (-1.41%)
HUM : 324.73 (+0.39%)
CHGCY : 16.2920 (-0.35%)
HZNP : 116.30 (+0.04%)
CSLLY : 86.8320 (-1.28%)
What Makes CSL Limited Sponsored ADR (CSLLY) a Good Fit for 'Trend Investing'

CSL Limited Sponsored ADR (CSLLY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made...

CSLLY : 86.8320 (-1.28%)
Why CSL Ltd Stock Could Be Worth a Look

FDA approval of costly--but worthwhile--drug leads the momentum that could make CSL Ltd an equally worthwhile investment.

CSL : 367.54 (-0.35%)
CSLLY : 86.8320 (-1.28%)
NVS : 92.58 (-0.54%)
BLUE : 0.9553 (-0.83%)
ARCT : 26.29 (-4.88%)
Why Arcturus Therapeutics Stock Is Skyrocketing Today

Investors are applauding Arcturus' collaboration with CSL.

CSL.AX : 271.400 (-0.45%)
CSLLY : 86.8320 (-1.28%)
ARCT : 26.29 (-4.88%)
Finalization of Vifor Pharma acquisition

Regulatory News:

CSL.AX : 271.400 (-0.45%)
OTC.VN : 0.310 (-10.14%)
CSLLY : 86.8320 (-1.28%)
uniQure announces closing of commercialization and license agreement with CSL Behring

Upfront payment of $450 million due to uniQure by May 13, 2021

CSLLY : 86.8320 (-1.28%)
ASX : 10.36 (-2.17%)
QURE : 4.72 (+1.07%)
The Latest: Mexico to lower virus alert level in many states

MEXICO CITY __ Mexico is reducing its COVID-19 alert level in about half of the country’s states amid a drop in infections and hospitalizations in many places, including the capital.

PFE : 25.37 (-0.20%)
CSL : 367.54 (-0.35%)
CSLLY : 86.8320 (-1.28%)
The Latest: Australia's 2nd largest city to begin lockdown

MELBOURNE, Australia — Australia’s second-largest city will begin its third lockdown due to a rapidly spreading COVID-19 cluster centered on hotel quarantine.

JNJ : 145.74 (+0.67%)
CSL : 367.54 (-0.35%)
CSLLY : 86.8320 (-1.28%)
uniQure Announces License Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy

~ CSL Behring Obtains Exclusive Global Rights to Develop and Commercialize uniQure’s Differentiated Gene Therapy Candidate for Hemophilia B ~

ASX : 10.36 (-2.17%)
CSLLY : 86.8320 (-1.28%)
QURE : 4.72 (+1.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 89.1500
2nd Resistance Point 88.7000
1st Resistance Point 88.3300
Last Price 86.8320
1st Support Level 87.5100
2nd Support Level 87.0600
3rd Support Level 86.6900

See More

52-Week High 105.1100
Fibonacci 61.8% 92.2748
Fibonacci 50% 88.3100
Last Price 86.8320
Fibonacci 38.2% 84.3452
52-Week Low 71.5100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar